Abstract
The genome projects in human and other species have made genetic data widely available and pose challenges as well as opportunities for statistical analysis. In this paper we elaborate the concept of integrated analysis of genetic data, such that most aspects of analyses can be done effectively and efficiently in environments with facility for database accessibility, graphics, mathematical/statistical routines, flexible programming language, re-use of available codes, Internet connectivity and availability. This extends an earlier discussion on software consolidation (Guo and Lange. Theor Pop Biol 57:1-11, 2000). A general context is laid out by recollecting the research paradigms for genetic mapping of complex traits and illustrated with the study of ageing, before turning to the computational tools currently used. We show that the R system (http://www.r-project.org) so far is the most comprehensive and widely available system. However, other commercial systems can potentially be successful. In particular, we compare SAS (http://www.sas.com), Stata (http://www.stata.com), S-PLUS (http://www.insightful.com) and give some indications of future development. Our investigation has important implications for both statisticians end other researchers actively engaged in analysis of genetic data.
Keywords: Complex traits, genetic epidemiology, integrated analysis, statistical and computational genetics
Current Bioinformatics
Title: Genetic Dissection of Complex Traits In Silico: Approaches, Problems and Solutions
Volume: 1 Issue: 3
Author(s): Jing Hua Zhao and Qihua Tan
Affiliation:
Keywords: Complex traits, genetic epidemiology, integrated analysis, statistical and computational genetics
Abstract: The genome projects in human and other species have made genetic data widely available and pose challenges as well as opportunities for statistical analysis. In this paper we elaborate the concept of integrated analysis of genetic data, such that most aspects of analyses can be done effectively and efficiently in environments with facility for database accessibility, graphics, mathematical/statistical routines, flexible programming language, re-use of available codes, Internet connectivity and availability. This extends an earlier discussion on software consolidation (Guo and Lange. Theor Pop Biol 57:1-11, 2000). A general context is laid out by recollecting the research paradigms for genetic mapping of complex traits and illustrated with the study of ageing, before turning to the computational tools currently used. We show that the R system (http://www.r-project.org) so far is the most comprehensive and widely available system. However, other commercial systems can potentially be successful. In particular, we compare SAS (http://www.sas.com), Stata (http://www.stata.com), S-PLUS (http://www.insightful.com) and give some indications of future development. Our investigation has important implications for both statisticians end other researchers actively engaged in analysis of genetic data.
Export Options
About this article
Cite this article as:
Hua Zhao Jing and Tan Qihua, Genetic Dissection of Complex Traits In Silico: Approaches, Problems and Solutions, Current Bioinformatics 2006; 1 (3) . https://dx.doi.org/10.2174/157489306777827982
DOI https://dx.doi.org/10.2174/157489306777827982 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Anticoagulation in Patients with Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
Current Medicinal Chemistry Coffee: A Dietary Intervention on Type 2 Diabetes?
Current Medicinal Chemistry Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: The Evolution of Cell Therapy Towards Enhancing Vascular Regeneration in the Clinic (Guest Editors: Drew Kuraitis and Erik J. Suuronen)]
Current Vascular Pharmacology Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension
Current Vascular Pharmacology Hypoxia in Pre-Eclampsia: Cause or Effect?
Current Women`s Health Reviews Graphical Abstracts
Inflammation & Allergy - Drug Targets (Discontinued) Tenofovir-Related Nephropathies in HIV-Infected Patients
Current Vascular Pharmacology Anti-Cancer, Pharmacokinetic and Biodistribution Studies of Cremophor EL Free Alternative Paclitaxel Formulation
Current Drug Safety Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Current Clinical Pharmacology Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease
Current Pharmaceutical Design Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Nano-constructed Carriers Loaded With Antioxidant: Boon For Cardiovascular System
Current Pharmaceutical Design Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Dynamics of Telomere Length in Different Age Groups in a Latvian Population
Current Aging Science Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry